Global News and Digital Insights
for the Healthcare Industry

AI may detect chances of lung cancer relapse, new study at NHS informs

Research conducted at The Royal Marsden NHS concluded that patients suffering from non-small cell lung cancer (NSCLC) can be monitored post-treatment with the help of artificial intelligence (AI). AI will readily predict any chance of cancer recurrence in patients who are at high-risk. This platform will render the treatment more effective in terms of outcome because practitioners will be able to treat such patients before relapse occurs. The model is based on a Machine Learning (ML) algorithm, which can efficiently detect hazardous outcomes beforehand. Experts believe that it will also lessen the need for in-office follow-up sessions.

Read More from NationalHealthExecutive

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn